Letter to the Editor
Letter to the Editor
/ VOLUME 6, ISSUE 4, DECEMBER 2024
Marium Amjad
As Pakistan recovers from its enduring battle with COVID-19, it remains grappling with an ongoing public health crisis driven by mosquito-borne diseases like malaria, dengue and chikungunya. For many years, these prevalent arboviral illnesses have posed serious health risks. However, following the outbreak of chikungunya in Karachi and other parts of the […] Read More
Letter to the Editor
/ VOLUME 6, ISSUE 3, SEPTEMBER 2024
Moiz Ahmed Khan and Summaiya Zafar
The Crimean–Congo hemorrhagic fever (CCHF) virus was first identified in 1944 in the Crimean Peninsula in Eastern Europe and subsequently in the Congo in 1956. It belongs to the genus Nairovirus from the family Bunyaviridae. It causes a severe disease which is spread to humans through an infected tick bite and/or contact with blood or tissue from infected humans or animals. Read More
Letter to the Editor
/ VOLUME 4, ISSUE 3, SEPTEMBER 2022
Ayşegül Nalça
The monkeypox (MPX) outbreak that started in the middle of May 2022 has spread to more than 30 countries, with around 8000 laboratory-confirmed cases as of July 8, 2022. It is expected to continue to spread throughout the world. Human MPX is a zoonotic disease caused by (...) Read More
Letter to the Editor
/ VOLUME 4, ISSUE 2, JUNE 2022
Oğuz Abdullah Uyaroğlu and Ömrüm Uzun
Dear Editor, In 2012, the American Board of Internal Medicine (ABIM) Foundation launched a health initiative campaign named Choosing Wisely to advance a national dialogue on avoiding unnecessary medical tests, treatments, and procedures. Subsequently, each specialty society developed evidence-based recommendation lists about tests and treatments that were overused and did not provide meaningful benefit for patients. Today, the Choosing Wisely campaign (...) Read More
Letter to the Editor
/ VOLUME 3, ISSUE 2, AUGUST 2021
Özlem Kurt-Azap and others
The burden of COVID-19 on healthcare workers (HCWs) is increasing day by day, particularly in countries with high incidence. Turkey was the fourth leading country after India, the USA and Brazil that reported the highest daily case numbers by (...) Read More
Letter to the Editor
/ VOLUME 2, ISSUE 3, DECEMBER 2020
Gökhan Aygün and others
Remdesivir is a novel nucleotide analogue antiviral drug with in vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (1). Food and Drug Administration (FDA) and Drug Controller General of India have authorized the emergency use for the treatment of COVID-19 under an Read More
Letter to the Editor
/ VOLUME 2, ISSUE 3, DECEMBER 2020
Güldane Cengiz Seval and others
COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been declared as a global pandemic and worldwide confirmed cases are currently approaching 76 million. And so far, thrombocytopenia has been observed in 5% of hospitalized COVID-19 patients and 8% of those in intensive care unit. Although the decrease in platelet counts was mild, confirmation of immune etiology has to be confirmed in those with Read More
Letter to the Editor
/ VOLUME 2, ISSUE 3, DECEMBER 2020
Şükran Köse and Yusuf Özbel
The COVID-19 outbreak continues to spread among people around the world, despite many measures taken by governments. Wearing a single-use mask, keeping social distance and hand hygiene are the main personal protective measures and need to be applied correctly by each person in the communities. These measures are very important, especially to prevent SARS-CoV-2 Read More
Letter to the Editor
/ VOLUME 2, ISSUE 2, AUGUST 2020
Yeşim Besli
An emerging illness in new-born chickens, characterized by gasping and listless, was described as “An apparently new respiratory disease of chicks” by Schalk and Hwan. Then it was discovered that the disease was communicable; however Read More